Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 658

1.

Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.

Cavalieri E, Rogan E.

Ann N Y Acad Sci. 2006 Nov;1089:286-301.

PMID:
17261777
[PubMed - indexed for MEDLINE]
2.

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T.

Biochim Biophys Acta. 2006 Aug;1766(1):63-78. Epub 2006 Apr 19. Review.

PMID:
16675129
[PubMed - indexed for MEDLINE]
Free Article
3.

A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.

Cavalieri EL, Rogan EG.

Ann N Y Acad Sci. 2004 Dec;1028:247-57. Review.

PMID:
15650250
[PubMed - indexed for MEDLINE]
4.

Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.

Cavalieri EL, Rogan EG, Chakravarti D.

Cell Mol Life Sci. 2002 Apr;59(4):665-81. Review.

PMID:
12022473
[PubMed - indexed for MEDLINE]
5.

Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?

Cavalieri EL, Rogan EG.

IUBMB Life. 2010 Oct;62(10):746-51. doi: 10.1002/iub.376.

PMID:
20945454
[PubMed - indexed for MEDLINE]
6.

A unified mechanism in the initiation of cancer.

Cavalieri EL, Rogan EG.

Ann N Y Acad Sci. 2002 Apr;959:341-54. Review.

PMID:
11976208
[PubMed - indexed for MEDLINE]
7.
8.

Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Cavalieri EL, Rogan EG.

J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):169-80. doi: 10.1016/j.jsbmb.2011.03.008. Epub 2011 Mar 21. Review.

PMID:
21397019
[PubMed - indexed for MEDLINE]
9.

Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

Li KM, Todorovic R, Devanesan P, Higginbotham S, Köfeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL.

Carcinogenesis. 2004 Feb;25(2):289-97. Epub 2003 Oct 24.

PMID:
14578156
[PubMed - indexed for MEDLINE]
Free Article
10.

NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

Singh S, Zahid M, Saeed M, Gaikwad NW, Meza JL, Cavalieri EL, Rogan EG, Chakravarti D.

J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):56-66. doi: 10.1016/j.jsbmb.2009.07.003. Epub 2009 Jul 21.

PMID:
19628038
[PubMed - indexed for MEDLINE]
11.

Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.

Markushin Y, Zhong W, Cavalieri EL, Rogan EG, Small GJ, Yeung ES, Jankowiak R.

Chem Res Toxicol. 2003 Sep;16(9):1107-17.

PMID:
12971798
[PubMed - indexed for MEDLINE]
12.

The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.

Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E.

Chem Res Toxicol. 2006 Jan;19(1):164-72.

PMID:
16411670
[PubMed - indexed for MEDLINE]
13.

The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Cavalieri E, Rogan E.

Mol Aspects Med. 2014 Apr;36:1-55. doi: 10.1016/j.mam.2013.08.002. Epub 2013 Aug 30.

PMID:
23994691
[PubMed - in process]
14.

Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases.

Cavalieri EL, Li KM, Balu N, Saeed M, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG.

Carcinogenesis. 2002 Jun;23(6):1071-7.

PMID:
12082031
[PubMed - indexed for MEDLINE]
Free Article
15.

Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.

Zhang Y, Gaikwad NW, Olson K, Zahid M, Cavalieri EL, Rogan EG.

Metabolism. 2007 Jul;56(7):887-94.

PMID:
17570247
[PubMed - indexed for MEDLINE]
16.

Inhibition of depurinating estrogen-DNA adduct formation by natural compounds.

Zahid M, Gaikwad NW, Rogan EG, Cavalieri EL.

Chem Res Toxicol. 2007 Dec;20(12):1947-53. Epub 2007 Nov 27.

PMID:
18039013
[PubMed - indexed for MEDLINE]
17.

Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.

Cavalieri EL, Kumar S, Todorovic R, Higginbotham S, Badawi AF, Rogan EG.

Chem Res Toxicol. 2001 Aug;14(8):1041-50.

PMID:
11511178
[PubMed - indexed for MEDLINE]
18.

Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.

Todorovic R, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG, Cavalieri EL.

Carcinogenesis. 2001 Jun;22(6):905-11.

PMID:
11375897
[PubMed - indexed for MEDLINE]
Free Article
19.

Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.

Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E.

Int J Cancer. 2007 Apr 15;120(8):1821-4.

PMID:
17230531
[PubMed - indexed for MEDLINE]
20.

Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity.

Saeed M, Zahid M, Gunselman SJ, Rogan E, Cavalieri E.

Steroids. 2005 Jan;70(1):29-35. Epub 2004 Nov 23.

PMID:
15610894
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk